Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorEscalera Guerrero, Sergio-
dc.contributor.advisorRami, Lorena-
dc.contributor.advisorBuch Cardona, Pau-
dc.contributor.authorTrimble, Rachel Mary-
dc.descriptionTreballs finals del Màster de Fonaments de Ciència de Dades, Facultat de matemàtiques, Universitat de Barcelona. Curs: 2020-2021. Tutor: Sergio Escalera Guerrero, Lorena Rami i Pau Buch Cardonaca
dc.description.abstract[en] The number of people with Alzheimer’s disease, a degenerative brain disorder, is projected to triple worldwide by 2060, with no current cure. There has been a paradigm shift in the diagnostic conceptualization of Alzheimer’s disease (AD) based on evidence suggesting that structural and biological changes start to occur during a preclinical phase beginning decennia prior to the emergence of symptoms. However diagnostic methods for this phase are invasive and costly, thus clinicians are searching for cognitive tools for screening the population before diagnosing them. The goal of this thesis is to support the clinicians in their search for these new cognitive tests for Preclinical AD (pre-AD) detection through machine learning. In particular to provide a tool for clinicians to validate if a test is sensitive enough to detect incipient cognitive dysfunction in pre-AD subjects. To achieve this we first investigated multiple classifiers and ensemble methods to find a suitable one for the datasets supplied by the clinicians. We incorporate data augmentation through Synthetic Minority Oversampling Technique (SMOTE) to deal with the imbalanced nature of the dataset. We also compute the importance for each individual feature using a technique that assigns a score to these features based on how useful they were during the classification. We found Random Forest to be the preferred choice among the tested algorithms. SMOTE proved to be a crucial step, improving both the AUC and most importantly the sensitivity. The traditional neuropsychological tests were not sensitive enough to detect incipient cognitive dysfunction in pre-AD subjects. While the new tapping tests were more sensitive. Our tool was also easily understandable for the clinicians thanks to the feature
dc.format.extent43 p.-
dc.rightscc-by-nc-nd (c) Rachel Mary Trimble, 2021-
dc.rightscodi: GPL (c) Rachel Mary Trimble, 2021-
dc.sourceMàster Oficial - Fonaments de la Ciència de Dades-
dc.subject.classificationAprenentatge automàtic-
dc.subject.classificationMalaltia d'Alzheimer-
dc.subject.classificationSistemes classificadors (Intel·ligència artificial)-
dc.subject.classificationTreballs de fi de màster-
dc.subject.otherMachine learning-
dc.subject.otherAlzheimer's disease-
dc.subject.otherLearning classifier systems-
dc.subject.otherMaster's theses-
dc.titleDetecting incipient cognitive dysfunction in Preclinical Alzheimer’s Disease subjectsca
Appears in Collections:Programari - Treballs de l'alumnat
Màster Oficial - Fonaments de la Ciència de Dades

Files in This Item:
File Description SizeFormat 
tfg_trimble_rachel_mary.pdfMemòria840.68 kBAdobe PDFView/Open
TFM2021-main.zipCodi font8.18 MBzipView/Open

This item is licensed under a Creative Commons License Creative Commons